VectorB2B is a One-Stop-Shop for Bacteriophage-based products, that provides highly qualified services of drug discovery and development from the bench to bedside (B2B). VectorB2B gathers the scattered capacities of the Portuguese academic and industrial shareholders in the sector of health biotechnology to provide integrated services in the development of new bacteriophage and endolysin products.
The following is a list of the broad spectrum of services offered by VectorB2B:
- Efficacy studies
- Pre-clinical toxicology studies (GLP, non-GLP)
- Process development from lab scale to GMP manufacturing
- Pre-formulation and formulation
- Clinical trials (Phase I-III)
- Regulatory support and dossier preparation